Obesity and carotid artery remodeling M. Kozakova; C. Palombo; C. Morizzo; K. Højlund; M. Hatunic; B. Balkau; P. M. Nilsson; E. Ferrannini Obesity and carotid artery remodeling Nutr Diabetes
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity H. Y. Kim; H. J. Lee; Y. J. Chang; M. Pichavant; S. A. Shore; K. A. Fitzgerald; Y. Iwakura; E. Israel; K. Bolger; J. Faul; R. H. DeKruyff; D. T. Umetsu Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity Nat Med
Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level K. Kearns; A. Dee; A. P. Fitzgerald; E. Doherty; I. J. Perry Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level BMC Public Health
Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis B. J. Kendall; J. H. Rubenstein; M. B. Cook; T. L. Vaughan; L. A. Anderson; L. J. Murray; N. J. Shaheen; D. A. Corley; A. K. Chandar; L. Li; K. B. Greer; A. Chak; H. B. El-Serag; D. C. Whiteman; A. P. Thrift Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis Clin Gastroenterol Hepatol
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol Insulin Resistance & Diabetes
Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes N. Irwin; I. A. Montgomery; F. P. O'Harte; P. Frizelle; P. R. Flatt Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes Int J Obes (Lond) Insulin Resistance & Diabetes
The esophagitis to adenocarcinoma sequence; the role of inflammation M. E. Kavanagh; K. E. O'Sullivan; C. O'Hanlon; J. N. O'Sullivan; J. Lysaght; J. V. Reynolds The esophagitis to adenocarcinoma sequence; the role of inflammation Cancer Lett
Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes N. Irwin; V. A. Gault; F. P. M. O'Harte; P. R. Flatt Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes Peptides Insulin Resistance & Diabetes
Opposing immune-metabolic signature in visceral versus subcutaneous adipose tissue in patients with adenocarcinoma of the oesophagus and the oesophagogastric junction A. B. Heeran; J. McCready; M. R. Dunne; N. E. Donlon; T. S. Nugent; A. Bhardwaj; K. A. J. Mitchelson; A. M. Buckley; N. Ravi; H. M. Roche; J. V. Reynolds; N. Lynam-Lennon; J. O’sullivan Opposing immune-metabolic signature in visceral versus subcutaneous adipose tissue in patients with adenocarcinoma of the oesophagus and the oesophagogastric junction Metabolites
Metabolomics in the developmental origins of obesity and its cardiometabolic consequences M. F. Hivert; W. Perng; S. M. Watkins; C. S. Newgard; L. C. Kenny; B. S. Kristal; M. E. Patti; E. Isganaitis; D. L. DeMeo; E. Oken; M. W. Gillman Metabolomics in the developmental origins of obesity and its cardiometabolic consequences J Dev Orig Health Dis